Market Overview

UPDATE: UBS Raises PT to $11 on Cott on Improving Margins and Free Cash Flows

Share:
Related COT
Bank Of America Upgrades Dr Pepper Snapple; Analysts Still Prefer Other Soft Drinks
Top 4 NYSE Stocks In The Beverages-Soft Drinks Industry With The Highest EPS Growth Forecast For Next 5 Years

UBS reiterated its Buy rating on Cott (NYSE: COT) and increased its price target from $10 to $11.

UBS noted, "We do not believe that COT is trading in-line with its ability to consistently generate FCF. We are raising our EPSe to account for debt paydown (lower interest). Following the debt paydown, during which they can pay dividend and repurchase shares, we assume bigger buybacks. In the interim, Cott's margin profile should improve as efficiencies are realized and cost inflation moderates."

Cott closed at $8.10 on Friday.

Latest Ratings for COT

DateFirmActionFromTo
Feb 2015CitigroupMaintainsBuy
Feb 2015JP MorganMaintainsNeutral
Feb 2015Stifel NicolausUpgradesHoldBuy

View More Analyst Ratings for COT
View the Latest Analyst Ratings

Posted-In: UBSAnalyst Color Price Target Intraday Update Analyst Ratings

 

Related Articles (COT)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→